TY - JOUR
T1 - Prevention of cell swelling with low chloride St. Thomas' Hospital solution improves postischemic myocardial recovery
AU - Jayawant, A. M.
AU - Stephenson, Jr
AU - Baumgarten, C. M.
AU - Damiano, Jr
PY - 1998
Y1 - 1998
N2 - Objective: In isolated myocytes cardioplegia-induced cell swelling can be prevented by lowering the KCI product by replacing Cl- with an impermeant ion. This study tested the hypothesis that Cl- substitution in St. Thomas' Hospital cardioplegic solution would result in superior myocardial protection in the intact, blood-perfused heart. Methods: Using a parabiotic, isolated rabbit heart Langendorff model, hearts were exposed to 1 hour of hypothermic (10°to 12°C), global ischemia followed by 30 minutes of reperfusion. Isosmotic cardioplegia was administered as a single 50 ml bolus of either standard St. Thomas' Hospital solution ([K+](o) x [Cl-](o) = 2566.4 (mmol/L)2) or low Cl- St. Thomas' Hospital solution ([K+](o) x [Cl-](o) = 700 (mmol/L)2). Chloride was replaced by a large, impermeant ion, methanesulfonate. Postreperfusion systolic function and atrioventricular conduction times were measured before ischemia and after reperfusion. Results: Hearts receiving low Cl- St. Thomas' Hospital cardioplegia demonstrated significantly better postischemic functional recovery (74% ± 3%) compared with those treated with standard high Cl- St. Thomas' Hospital solution (55% ± 4%, p = 0.003). In addition, atrioventricular conduction times remained normal in the low Cl- group but were significantly prolonged in the St. Thomas' Hospital group. Conclusions: Lowering the KCl product of St. Thomas' Hospital solution makes it isotonic with plasma and prevents cellular edema. This ameliorates the detrimental functional and electrophysiologic sequelae of hypothermic, hyperkalemic cardioplegia.
AB - Objective: In isolated myocytes cardioplegia-induced cell swelling can be prevented by lowering the KCI product by replacing Cl- with an impermeant ion. This study tested the hypothesis that Cl- substitution in St. Thomas' Hospital cardioplegic solution would result in superior myocardial protection in the intact, blood-perfused heart. Methods: Using a parabiotic, isolated rabbit heart Langendorff model, hearts were exposed to 1 hour of hypothermic (10°to 12°C), global ischemia followed by 30 minutes of reperfusion. Isosmotic cardioplegia was administered as a single 50 ml bolus of either standard St. Thomas' Hospital solution ([K+](o) x [Cl-](o) = 2566.4 (mmol/L)2) or low Cl- St. Thomas' Hospital solution ([K+](o) x [Cl-](o) = 700 (mmol/L)2). Chloride was replaced by a large, impermeant ion, methanesulfonate. Postreperfusion systolic function and atrioventricular conduction times were measured before ischemia and after reperfusion. Results: Hearts receiving low Cl- St. Thomas' Hospital cardioplegia demonstrated significantly better postischemic functional recovery (74% ± 3%) compared with those treated with standard high Cl- St. Thomas' Hospital solution (55% ± 4%, p = 0.003). In addition, atrioventricular conduction times remained normal in the low Cl- group but were significantly prolonged in the St. Thomas' Hospital group. Conclusions: Lowering the KCl product of St. Thomas' Hospital solution makes it isotonic with plasma and prevents cellular edema. This ameliorates the detrimental functional and electrophysiologic sequelae of hypothermic, hyperkalemic cardioplegia.
UR - http://www.scopus.com/inward/record.url?scp=0031955391&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031955391&partnerID=8YFLogxK
U2 - 10.1016/S0022-5223(98)70421-0
DO - 10.1016/S0022-5223(98)70421-0
M3 - Article
C2 - 9605091
AN - SCOPUS:0031955391
SN - 0022-5223
VL - 115
SP - 1196
EP - 1202
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 5
ER -